NO20023385L - Etanolopplösning av (-)-cis-2-(2-klorofenyl)-5,7-dihydroksy- 8(4R-(3S-hydroksy-1-metyl)piperidinyl)-4H-1-benzopyran-4-on - Google Patents

Etanolopplösning av (-)-cis-2-(2-klorofenyl)-5,7-dihydroksy- 8(4R-(3S-hydroksy-1-metyl)piperidinyl)-4H-1-benzopyran-4-on

Info

Publication number
NO20023385L
NO20023385L NO20023385A NO20023385A NO20023385L NO 20023385 L NO20023385 L NO 20023385L NO 20023385 A NO20023385 A NO 20023385A NO 20023385 A NO20023385 A NO 20023385A NO 20023385 L NO20023385 L NO 20023385L
Authority
NO
Norway
Prior art keywords
benzopyran
piperidinyl
chlorophenyl
dihydroxy
cis
Prior art date
Application number
NO20023385A
Other languages
English (en)
Other versions
NO20023385D0 (no
NO322626B1 (no
Inventor
Kurt M Kesseler
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of NO20023385D0 publication Critical patent/NO20023385D0/no
Publication of NO20023385L publication Critical patent/NO20023385L/no
Publication of NO322626B1 publication Critical patent/NO322626B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO20023385A 2000-01-18 2002-07-12 Hydroklorid-etanol-solvatform av (-)-cis-2-(2-klorfenyl)-5,7-dihydroksy-8[4R-(3S-hydroksy-1-metyl)piperidinyl]-4H-1-benzopyran-4-on, fremgangsmate for fremstilling derav og anvendelse derav ved behandling av cancer. NO322626B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48781500A 2000-01-18 2000-01-18
PCT/US2001/000520 WO2001053294A1 (en) 2000-01-18 2001-01-08 Ethanol solvate of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8[4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one

Publications (3)

Publication Number Publication Date
NO20023385D0 NO20023385D0 (no) 2002-07-12
NO20023385L true NO20023385L (no) 2002-08-27
NO322626B1 NO322626B1 (no) 2006-11-06

Family

ID=23937213

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023385A NO322626B1 (no) 2000-01-18 2002-07-12 Hydroklorid-etanol-solvatform av (-)-cis-2-(2-klorfenyl)-5,7-dihydroksy-8[4R-(3S-hydroksy-1-metyl)piperidinyl]-4H-1-benzopyran-4-on, fremgangsmate for fremstilling derav og anvendelse derav ved behandling av cancer.

Country Status (26)

Country Link
EP (1) EP1252155B1 (no)
JP (1) JP2003520798A (no)
KR (1) KR100825530B1 (no)
CN (1) CN1395577A (no)
AR (1) AR027226A1 (no)
AT (1) ATE284400T1 (no)
AU (1) AU2001230869A1 (no)
BR (1) BR0107724A (no)
CA (1) CA2397594C (no)
CZ (1) CZ301235B6 (no)
DE (1) DE60107652T2 (no)
DK (1) DK1252155T3 (no)
EA (1) EA005182B1 (no)
ES (1) ES2228800T3 (no)
HU (1) HU225155B1 (no)
IL (2) IL150643A0 (no)
MX (1) MXPA02006965A (no)
NO (1) NO322626B1 (no)
NZ (1) NZ520281A (no)
PL (1) PL201690B1 (no)
PT (1) PT1252155E (no)
SI (1) SI1252155T1 (no)
SK (1) SK287216B6 (no)
TW (1) TWI293072B (no)
WO (1) WO2001053294A1 (no)
ZA (1) ZA200205640B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL264950B2 (en) 2016-08-23 2024-01-01 Eisai R&D Man Co Ltd Combined treatments for the treatment of malignant liver cell carcinoma
IL269357B1 (en) 2017-03-16 2024-06-01 Eisai R&D Man Co Ltd A combination of Era inhibitors and a CDK4/6 inhibitor to be used in a method to treat breast cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN164232B (no) * 1986-04-11 1989-02-04 Hoechst India
DE3836676A1 (de) * 1988-10-28 1990-05-03 Hoechst Ag Die verwendung von 4h-1-benzopyran-4-on-derivaten, neue 4h-1-benzopyran-4-on-derivate und diese enthaltende arzneimittel
US5284856A (en) * 1988-10-28 1994-02-08 Hoechst Aktiengesellschaft Oncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one derivatives
US5908934A (en) * 1996-09-26 1999-06-01 Bristol-Myers Squibb Company Process for the preparation of chiral ketone intermediates useful for the preparation of flavopiridol and analogs

Also Published As

Publication number Publication date
KR100825530B1 (ko) 2008-04-25
SK287216B6 (sk) 2010-03-08
WO2001053294A1 (en) 2001-07-26
NO20023385D0 (no) 2002-07-12
JP2003520798A (ja) 2003-07-08
ES2228800T3 (es) 2005-04-16
AU2001230869A1 (en) 2001-07-31
EA200200776A1 (ru) 2002-12-26
PT1252155E (pt) 2005-04-29
CA2397594C (en) 2010-03-23
EP1252155B1 (en) 2004-12-08
EP1252155A1 (en) 2002-10-30
SK10372002A3 (sk) 2002-12-03
ZA200205640B (en) 2003-11-26
SI1252155T1 (en) 2005-06-30
PL355992A1 (en) 2004-05-31
TWI293072B (en) 2008-02-01
AR027226A1 (es) 2003-03-19
DE60107652T2 (de) 2005-12-22
HU225155B1 (en) 2006-07-28
HUP0204297A2 (hu) 2003-04-28
DK1252155T3 (da) 2005-04-04
IL150643A0 (en) 2003-02-12
CA2397594A1 (en) 2001-07-26
MXPA02006965A (es) 2004-09-06
HUP0204297A3 (en) 2005-04-28
IL150643A (en) 2009-08-03
NZ520281A (en) 2004-04-30
CZ301235B6 (cs) 2009-12-16
ATE284400T1 (de) 2004-12-15
BR0107724A (pt) 2002-10-01
NO322626B1 (no) 2006-11-06
PL201690B1 (pl) 2009-04-30
KR20020069514A (ko) 2002-09-04
CN1395577A (zh) 2003-02-05
CZ20022467A3 (cs) 2002-10-16
EA005182B1 (ru) 2004-12-30
DE60107652D1 (de) 2005-01-13

Similar Documents

Publication Publication Date Title
AR028567A1 (es) Nuevos derivados de fenil-propargileter
AR028596A1 (es) Nuevos derivados de fenilglicina
IS6488A (is) Setin arýlpýrazín
NO20020930L (no) Enkelturs, flerisolerings, brönnfraktureringssystem
ATE333445T1 (de) Pyrazolderivate
DE60214428D1 (de) 1, 4-dihydro-1, 4-diphenylpyridin-derivate
ATE441631T1 (de) Phenylpiperidinderivate als serotonin- wiederaufnahmehemmer
NO20013945L (no) Fremstilling av isoflavonderivater
EE05386B1 (et) Ftalasinoon-piperidinoderivaadid,ÁnendeÁkasutamineÁjaÁravim
DE60123153D1 (de) Sprachgesteuertes Browsersystem
NO20031386L (no) Substituerte C-cykloheksylmetylaminderivater
NO20032731D0 (no) Fremgangsmåte for fremstilling av sulfonamid-substituerte imidazotriazinoner
ATE309220T1 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2- carbonsäurederivate
PT1322592E (pt) Derivados substituidos de 1-aminobutan-3-ol
AR028607A1 (es) Derivados de 1,4-diazepan-2,5-diona
ATE282021T1 (de) Substituierte aminomethyl-phenyl- cyclohexanderivate
DE60201463D1 (de) Indanon-Derivate als Duftstoffe
NO20023385L (no) Etanolopplösning av (-)-cis-2-(2-klorofenyl)-5,7-dihydroksy- 8(4R-(3S-hydroksy-1-metyl)piperidinyl)-4H-1-benzopyran-4-on
DE60110046D1 (de) Cyclische hexapeptidderivate
DE60138636D1 (de) Mehrstufiger schraubenrotor
DE60107191D1 (de) Herstellung von 2-Hydrocarbyl-2-Adamantylacrylaten
DE50112454D1 (de) Substituierte 5-amino-1-penten-3-ol-derivate
NO20040913L (no) Nye 2,4-diaminotiazolderivater
NO20004364D0 (no) Nye saltformer av (2E)-5-amino-5-metylheks-2-ensyre-N-metyl-N-
DK1343806T3 (da) Methylensteroider som nye androgener

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees